Axcella Health Inc.
AXLADelisted Feb 15, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Mar 3, 2023; 15 institutions reported holding it in 13F filings for Q3 2023, worth $17.1M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Axcella Health Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 34 | 35 | +1 |
| Shares | 34.1M | 49.2M | +15.0M (+44.1%) |
| Value | $58.3M | $15.9M | −$42.5M (−72.8%) |
New holders (8)
Institutions that held Axcella Health Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Caas Capital Management LP | 381,147 | $124.8K | 0.02% |
| Millennium Management LLC | 97,359 | $32.0K | 0.00% |
| Shay Capital LLC | 50,000 | $16.4K | 0.01% |
| Jane Street Group, LLC | 32,140 | $10.5K | 0.00% |
| StoneX Group Inc. | 15,000 | $4.91K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 13,979 | $4.58K | 0.00% |
| Belpointe Asset Management LLC | 1,143 | $374 | 0.00% |
| Bank of America Corp | 78 | $26 | 0.00% |
Sold out (7)
Institutions that held Axcella Health Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Artal Group S.A. | 712,500 | $1.22M |
| Dimensional Fund Advisors LP | 113,085 | $194.0K |
| Commonwealth Equity Services, LLC | 20,000 | $34.0K |
| Cutter & CO Brokerage, Inc. | 19,800 | $34.0K |
| UBS Group AG | 3,133 | $5.00K |
| Morgan Stanley | 5 | $0 |
| Simplex Trading, LLC | 62 | $0 |